Large gap with delayed quotes
|
Last quote
04/27/2026
-
17:55:35
|
Bid
04/27/2026 -
17:56:19
|
Bid Volume |
Ask
04/27/2026 -
17:56:19
|
Ask Volume |
|---|---|---|---|---|
|
36.48
-0.14
(
-0.38% )
|
36.49
|
100 |
36.51
|
200 |
Analysis date: 24.04.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 21.04.2026.
Interest
Strong
Strong
Three stars since 21.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 21.04.2026 at a price of 36.28.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 17.03.2026.
4wk Rel Perf
11.89%
11.89%
The four-week dividend-adjusted overperformance versus SP500 is 11.89%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.81%.
Mkt Cap in $bn
5.85
5.85
With a market capitalization between $2 & $8bn, TG THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
1.01
1.01
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
14
14
The estimated PE is for the year 2028.
LT Growth
14.09%
14.09%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
85
85
For 1% of index variation, the stock varies on average by 0.85%.
Correlation
0.24
0.24
Stock movements are strongly independent of index variations.
Value at Risk
19.28
19.28
The value at risk is estimated at USD 19.28. The risk is therefore 52.65%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
09.02.2021
09.02.2021